REATA PHARMACEUTICALS INC short interest in 2022
In 2022, REATA PHARMACEUTICALS INC's disclosed short interest ran from 10.62% of shares outstanding on 14 Jan 2022 to 21.77% on 30 Dec 2022, a change of +11.15 percentage points. The year's high was 21.77% on 30 Dec 2022 and its low 6.64% on 28 Feb 2022, averaging 13.67% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.94 days on 29 Jul 2022. Full history: REATA PHARMACEUTICALS INC.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023
2022 in figures
- Start of year
- 10.62% (14 Jan 2022)
- End of year
- 21.77% (30 Dec 2022)
- Change
- +11.15 pp
- High
- 21.77% (30 Dec 2022)
- Low
- 6.64% (28 Feb 2022)
- Average
- 13.67%
- Highest days to cover
- 22.94 (29 Jul 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 10.62% | 5.43 | |
| 31 Jan 2022 | 8.10% | 4.27 | |
| 15 Feb 2022 | 6.88% | 4.64 | |
| 28 Feb 2022 | 6.64% | 3.19 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 9.31% | 5.83 | |
| 31 Mar 2022 | 10.42% | 3.45 | |
| 14 Apr 2022 | 12.61% | 9.42 | |
| 29 Apr 2022 | 13.96% | 9.54 | |
| 13 May 2022 | 13.70% | 9.71 | 10-Q filed, results (8-K) |
| 31 May 2022 | 12.81% | 9.10 | |
| 15 Jun 2022 | 13.49% | 11.59 | |
| 30 Jun 2022 | 13.75% | 11.17 | |
| 15 Jul 2022 | 13.78% | 15.33 | |
| 29 Jul 2022 | 13.85% | 22.94 | |
| 15 Aug 2022 | 12.90% | 4.52 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 11.46% | 4.69 | |
| 15 Sep 2022 | 13.57% | 3.19 | |
| 30 Sep 2022 | 14.09% | 8.40 | |
| 14 Oct 2022 | 14.62% | 6.55 | |
| 31 Oct 2022 | 18.17% | 6.14 | |
| 15 Nov 2022 | 19.91% | 8.36 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 21.71% | 15.87 | |
| 15 Dec 2022 | 19.96% | 18.20 | |
| 30 Dec 2022 | 21.77% | 18.29 |
See also: REATA PHARMACEUTICALS INC's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.